418 related articles for article (PubMed ID: 35582386)
1. Notch signaling in female cancers: a multifaceted node to overcome drug resistance.
Giuli MV; Mancusi A; Giuliani E; Screpanti I; Checquolo S
Cancer Drug Resist; 2021; 4(4):805-836. PubMed ID: 35582386
[TBL] [Abstract][Full Text] [Related]
2. Targeting Notch signaling pathway as an effective strategy in overcoming drug resistance in ovarian cancer.
Akbarzadeh M; Akbarzadeh S; Majidinia M
Pathol Res Pract; 2020 Nov; 216(11):153158. PubMed ID: 32829107
[TBL] [Abstract][Full Text] [Related]
3. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells.
Bao B; Wang Z; Ali S; Kong D; Li Y; Ahmad A; Banerjee S; Azmi AS; Miele L; Sarkar FH
Cancer Lett; 2011 Aug; 307(1):26-36. PubMed ID: 21463919
[TBL] [Abstract][Full Text] [Related]
4. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
BeLow M; Osipo C
Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
[TBL] [Abstract][Full Text] [Related]
5. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.
Bocci F; Jolly MK; George JT; Levine H; Onuchic JN
Oncotarget; 2018 Jul; 9(52):29906-29920. PubMed ID: 30042822
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance.
D'Amico M; De Amicis F
Cancer Drug Resist; 2022; 5(4):939-953. PubMed ID: 36627893
[TBL] [Abstract][Full Text] [Related]
7. Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells.
Xie M; Zhang L; He CS; Xu F; Liu JL; Hu ZH; Zhao LP; Tian Y
J Cell Biochem; 2012 May; 113(5):1501-13. PubMed ID: 22173954
[TBL] [Abstract][Full Text] [Related]
8. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
9. Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
Wang L; Dai G; Yang J; Wu W; Zhang W
Med Sci Monit; 2018 Jun; 24():4046-4053. PubMed ID: 29899322
[TBL] [Abstract][Full Text] [Related]
10. Regulation of EMT by Notch signaling pathway in tumor progression.
Li Y; Ma J; Qian X; Wu Q; Xia J; Miele L; Sarkar FH; Wang Z
Curr Cancer Drug Targets; 2013 Nov; 13(9):957-62. PubMed ID: 24168187
[TBL] [Abstract][Full Text] [Related]
11. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
[TBL] [Abstract][Full Text] [Related]
12. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N
Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690
[TBL] [Abstract][Full Text] [Related]
13. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.
Kang J; Kim E; Kim W; Seong KM; Youn H; Kim JW; Kim J; Youn B
J Biol Chem; 2013 Sep; 288(38):27343-27357. PubMed ID: 23902763
[TBL] [Abstract][Full Text] [Related]
14. Re-establishing Apoptosis Competence in Bone Associated Cancers via Communicative Reprogramming Induced Through Notch Signaling Inhibition.
Colombo M; Platonova N; Giannandrea D; Palano MT; Basile A; Chiaramonte R
Front Pharmacol; 2019; 10():145. PubMed ID: 30873026
[TBL] [Abstract][Full Text] [Related]
15. Notch Signaling Pathway and Endocrine Resistance in Breast Cancer.
Bai JW; Wei M; Li JW; Zhang GJ
Front Pharmacol; 2020; 11():924. PubMed ID: 32636747
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
17. Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application.
Yuan X; Wu H; Han N; Xu H; Chu Q; Yu S; Chen Y; Wu K
J Hematol Oncol; 2014 Dec; 7():87. PubMed ID: 25477004
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT.
De Francesco EM; Maggiolini M; Musti AM
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29996493
[TBL] [Abstract][Full Text] [Related]
19. Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.
Xie M; He CS; Wei SH; Zhang L
Eur J Cancer; 2013 Nov; 49(16):3559-72. PubMed ID: 23916913
[TBL] [Abstract][Full Text] [Related]
20. Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells.
Zhang L; Sha J; Yang G; Huang X; Bo J; Huang Y
Cell Cycle; 2017 May; 16(10):999-1007. PubMed ID: 28388267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
